Mr. Main, I would like to hear more from the company with respect with new formulations and how they would exclude the generics. I am just so disillusioned with our healthcare system (insurers, PBMs, pharmacies, even docs and govts) that I fear patients will still be pushed towards generics. But since that is a fear I have and not direct knowledge I am looking forward to hearing from the company or the FDA and would be thrilled to see a logical path to that end. Regaining the U.S. market in full will make all of us long timers whole again.
Market Data 
Markets 
